A Long-Term Clinical Study of SFPP in Patients with Osteoarthritis

Trial Profile

A Long-Term Clinical Study of SFPP in Patients with Osteoarthritis

Completed
Phase of Trial: Phase III

Latest Information Update: 26 May 2016

At a glance

  • Drugs Esflurbiprofen (Primary)
  • Indications Osteoarthritis
  • Focus Adverse reactions
  • Sponsors Taisho Pharmaceutical
  • Most Recent Events

    • 26 May 2016 Results published in the Clinical Drug Investigation
    • 20 Jan 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top